Haijing Deng

1.6k total citations
19 papers, 954 citations indexed

About

Haijing Deng is a scholar working on Molecular Biology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haijing Deng has authored 19 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Hepatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haijing Deng's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Haijing Deng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Haijing Deng collaborates with scholars based in China, Hong Kong and United States. Haijing Deng's co-authors include Ning Lyu, Ming Zhao, Shaolong Li, Qiankun Xie, Luwen Mu, Yanan Kong, Jibin Li, Anna Kan, Peihong Wu and Ming Shi and has published in prestigious journals such as Nature Communications, Journal of Hepatology and Cellular Microbiology.

In The Last Decade

Haijing Deng

19 papers receiving 948 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Haijing Deng 364 325 225 216 201 19 954
Yinan Shen 201 0.6× 205 0.6× 97 0.4× 362 1.7× 105 0.5× 36 793
Steffen Zopf 215 0.6× 301 0.9× 68 0.3× 188 0.9× 85 0.4× 44 1.0k
Zhongming Tan 248 0.7× 265 0.8× 151 0.7× 175 0.8× 42 0.2× 23 891
Solange Romagnoli 63 0.2× 239 0.7× 110 0.5× 292 1.4× 183 0.9× 35 1.0k
Hiroyuki Shimomura 491 1.3× 236 0.7× 108 0.5× 98 0.5× 46 0.2× 58 1.0k
Kiyotaka Kurachi 77 0.2× 218 0.7× 106 0.5× 368 1.7× 219 1.1× 65 875
Xu Che 131 0.4× 595 1.8× 513 2.3× 359 1.7× 183 0.9× 81 1.1k
Mitsue Yasoshima 439 1.2× 171 0.5× 52 0.2× 134 0.6× 65 0.3× 30 975
Naoki Morimoto 210 0.6× 126 0.4× 70 0.3× 108 0.5× 193 1.0× 59 681
Hwei-Fang Tsai 111 0.3× 229 0.7× 87 0.4× 139 0.6× 43 0.2× 23 772

Countries citing papers authored by Haijing Deng

Since Specialization
Citations

This map shows the geographic impact of Haijing Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijing Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijing Deng more than expected).

Fields of papers citing papers by Haijing Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haijing Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijing Deng. The network helps show where Haijing Deng may publish in the future.

Co-authorship network of co-authors of Haijing Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Haijing Deng. A scholar is included among the top collaborators of Haijing Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haijing Deng. Haijing Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Yi‐Ling, Derek Lee, Mengjie Wu, et al.. (2025). Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modification. Journal of Hepatology. 83(6). 1338–1352. 2 indexed citations
2.
Liu, Yongxiang, Haijing Deng, Feng Cheng, et al.. (2024). Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma. Nature Communications. 15(1). 1754–1754. 20 indexed citations
3.
Kan, Anna, Shuang Liu, Minke He, et al.. (2023). MZF1 promotes tumour progression and resistance to anti-PD-L1 antibody treatment in hepatocellular carcinoma. JHEP Reports. 6(1). 100939–100939. 8 indexed citations
4.
5.
Lyu, Ning, Yan Zeng, Yanan Kong, et al.. (2021). Ferroptosis is involved in the progression of hepatocellular carcinoma through the circ0097009/miR-1261/SLC7A11 axis. Annals of Translational Medicine. 9(8). 675–675. 74 indexed citations
6.
Deng, Haijing, Anna Kan, Ning Lyu, et al.. (2021). Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 9(6). e002305–e002305. 119 indexed citations
7.
Lyu, Ning, Yanan Kong, Xiaoxian Li, et al.. (2020). Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study. Frontiers in Oncology. 10. 580241–580241. 44 indexed citations
8.
Liang, Zhixian, Reilly L. Kidwell, Haijing Deng, & Qi Xie. (2020). Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer. Cancer Biology and Medicine. 17(1). 9–19. 30 indexed citations
9.
10.
Lyu, Ning, Yanan Kong, Tao Pan, et al.. (2019). Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread. Journal of Vascular and Interventional Radiology. 30(3). 349–357.e2. 23 indexed citations
11.
Lyu, Ning, Yanan Kong, Tao Pan, et al.. (2019). Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma. International Journal of Hyperthermia. 36(1). 1002–1010. 6 indexed citations
12.
Lyu, Ning, Yanan Kong, Luwen Mu, et al.. (2018). Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma. Journal of Hepatology. 69(1). 60–69. 196 indexed citations
13.
Mu, Luwen, Tao Pan, Ning Lyu, et al.. (2018). CT-guided percutaneous radiofrequency ablation for lung neoplasms adjacent to the pericardium. Lung Cancer. 122. 25–31. 12 indexed citations
14.
Li, Shaolong, Xue Han, Ning Lyu, et al.. (2018). Mechanism and prognostic value of indoleamine 2,3‐dioxygenase 1 expressed in hepatocellular carcinoma. Cancer Science. 109(12). 3726–3736. 30 indexed citations
15.
16.
Peng, Haibing, et al.. (2017). Protective effects of oleanolic acid on oxidative stress and the expression of cytokines and collagen by the AKT/NF-κB pathway in silicotic rats. Molecular Medicine Reports. 15(5). 3121–3128. 28 indexed citations
17.
Mu, Luwen, Tao Pan, Ning Lyu, et al.. (2017). Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results. International Journal of Hyperthermia. 34(1). 59–67. 21 indexed citations
18.
Zhu, Xun, Zhenjian He, Yiwen Hu, et al.. (2014). MicroRNA-30e* Suppresses Dengue Virus Replication by Promoting NF-κB–Dependent IFN Production. PLoS neglected tropical diseases. 8(8). e3088–e3088. 74 indexed citations
19.
Zhu, Xun, Zhenjian He, Jie Yuan, et al.. (2014). IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection. Cellular Microbiology. 17(1). 105–118. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yinan Shen Breakdown of academic impact, for papers by Steffen Zopf Breakdown of academic impact, for papers by Zhongming Tan Breakdown of academic impact, for papers by Solange Romagnoli Breakdown of academic impact, for papers by Hiroyuki Shimomura Breakdown of academic impact, for papers by Kiyotaka Kurachi Breakdown of academic impact, for papers by Xu Che Breakdown of academic impact, for papers by Mitsue Yasoshima Breakdown of academic impact, for papers by Naoki Morimoto Breakdown of academic impact, for papers by Hwei-Fang Tsai
Rankless by CCL
2026